FDA nanotechnology draft guidance represents ‘marginal progress’ – petition group
date:May 10, 2012
effects, added the statement.


Existing research has flagged-up several potential nanotechnology-related health risks, including the dangers surrounding the ability of nanomaterials to enter the bloodstream through skin contact, ingestion and inhalation.


Mandatory regulations


While agreeing that the FDA stance on nanotechnology has improved, CFS attorney George Kimbrell called on the Agency to implement more than just voluntary guidance.


As these new responses show, the agency is no long
5/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
12/29 20:16